BiotechTube
Home/Kyverna Therapeutics/Peter Maag
PM

Peter Maag

Chief Executive Officer & Chairman

Kyverna Therapeutics

Therapeutic Areas

Autoimmune DiseasesImmunology

Kyverna Therapeutics Pipeline

DrugIndicationPhase
KYV-101 (mivocabtagene autoleucel)Lupus NephritisPhase 2
KYV-102Autoimmune DiseasesPhase 1
KYV-201Autoimmune DiseasesPreclinical

Leadership Team at Kyverna Therapeutics

DR
Dominik Rüttinger
Chief Medical Officer
JV
Jens Vogel
Chief Scientific Officer & Head of R&D
KF
Kathleen Fan
Chief Financial Officer
MJ
Matthew J. Warren
Chief Business Officer
View full Kyverna Therapeutics profile